Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year.

Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. kAm%96 4@>3:?65 4@>A2?J H:== 92G6 2 9F86 DE23=6 @7 9@FD69@=5 3C2?5D F?56C @?6 C@@7[ AFEE:?8 z6?GF6’D {:DE6C:?6 >@FE9H2D9 2?5 q2?5\p:5 D:56\3J\D:56 H:E9 z:>36C=J\r=2C<’D r@EE@?6==6 E@:=6E A2A6C[ wF88:6D 2?5 z=66?6I E:DDF6D] xE H:== 2=D@ 86?6C2E6 23@FE Sba 3:==:@? :? 2??F2= C6G6?F6]k^Am kAmz6?GF6 92D DA6?E 2 C6=2E:G6=J 3

See Full Page